Presbyopia

Phase 2b study highlights effectiveness of pilocarpine in treating presbyopia

A recent Phase 2b clinical trial demonstrated that 0.4% pilocarpine HCl (CSF-1), either alone or in combination with diclofenac sodium, significantly improves near vision in individuals with presbyopia. The randomized, double-masked study included 166 adults aged 45-64 treated with either pilocarpine HCl alone, a fixed-dose combination (FDC) of pilocarpine HCl...